iotaMotion's Groundbreaking Approach to Cochlear Implants
iotaMotion, Inc. is at the forefront of innovation in medical technology, particularly in the field of cochlear implants. The company recently unveiled its iotaSOFT Insertion System, marking a significant advancement in robotic-assisted surgery. This cutting-edge technology is currently undergoing pre-market clinical investigation at University Hospital of Zurich, led by the esteemed Professor Alexander Huber.
Advancing Cochlear Surgery with Robotic Assistance
In a recent study titled "Analysis of electrocochleographic signals during speed-controlled cochlear implant electrode array insertion in a non-randomized controlled trial," iotaMotion’s revolutionary system showcases unmatched control over the electrode array insertion process. The iotaSOFT Insertion System has already been successfully implemented in over 750 cases within the United States, emphasizing its effectiveness and reliability in enhancing surgical outcomes.
The Importance of the Collaboration
Professor Huber expressed the importance of this collaboration, stating, "Bringing this new robotic-assisted technology for cochlear implantation to University of Zurich is extremely important for our team. It will allow us to continue advancing cochlear implant care and explore innovative techniques that have never been used clinically prior to this study." This partnership underscores the commitment both organizations have towards improving patient care and advancing medical technology.
Potential for Future Developments
This clinical investigation utilizes robotic control for electrode insertion while simultaneously analyzing cochlear function through electrocochleography (ECochG) signals. The findings from this study are expected to pave the way for future breakthroughs in cochlear implant programming and strategies for hearing preservation, opening new avenues for enhanced patient outcomes.
Milestone for iotaMotion
Mike Lobinsky, the President and CEO of iotaMotion, stated, "This represents a major milestone for us as we expand beyond the United States with our technology. The team in Zurich has been an outstanding partner, and we look forward to deepening this collaboration." With plans for broader availability of the iotaSOFT Insertion System set for 2026, iotaMotion is poised to play a vital role in the global cochlear implant landscape.
About iotaMotion
Founded in the heart of St. Paul, MN, iotaMotion, Inc. is dedicated to transforming cochlear implant surgery through its robotic-assisted solutions. Designed for a slow and consistent electrode array insertion, the iotaSOFT Insertion System aims to protect delicate intracochlear structures effectively. While it is commercially available in the United States, its clinical exploration continues in various international markets, aimed at refining cochlear implant procedures.
Frequently Asked Questions
What is the iotaSOFT Insertion System?
The iotaSOFT Insertion System is a robotic-assisted technology designed to enhance cochlear implant surgeries by providing controlled insertion of the electrode array.
Where is the iotaSOFT Insertion System being tested?
The system is currently in use as part of a clinical investigation at University Hospital of Zurich in Switzerland.
What was the focus of the recent study conducted?
The study focused on analyzing electrocochleographic signals during the insertion of cochlear implant electrodes to understand the relationship between insertion dynamics and cochlear function.
Who led the clinical investigation at the University Hospital of Zurich?
Professor Alexander Huber led the clinical investigation at the University Hospital of Zurich, emphasizing the importance of this innovative technology for cochlear implantation.
When is the iotaSOFT Insertion System expected to be widely available?
The wider availability of the iotaSOFT Insertion System is planned for 2026, following the current pre-market clinical investigation phase.
